Entity Details

Primary name PROS_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP07225
EntryNamePROS_HUMAN
FullNameVitamin K-dependent protein S
TaxID9606
Evidenceevidence at protein level
Length676
SequenceStatuscomplete
DateCreated1988-04-01
DateModified2021-06-02

Ontological Relatives

GenesPROS1

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0002576 platelet degranulation
GO:0004866 endopeptidase inhibitor activity
GO:0005509 calcium ion binding
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005789 endoplasmic reticulum membrane
GO:0005796 Golgi lumen
GO:0005886 plasma membrane
GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport
GO:0007596 blood coagulation
GO:0030449 regulation of complement activation
GO:0031093 platelet alpha granule lumen
GO:0042730 fibrinolysis
GO:0050900 leukocyte migration
GO:0070062 extracellular exosome
GO:0072562 blood microparticle

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000152 EGF-type aspartate/asparagine hydroxylation sitePTMPTM
IPR000294 Gamma-carboxyglutamic acid-rich (GLA) domainDomainDomain
IPR000742 EGF-like domainDomainDomain
IPR001791 Laminin G domainDomainDomain
IPR001881 EGF-like calcium-binding domainDomainDomain
IPR009030 Growth factor receptor cysteine-rich domain superfamilyFamilyHomologous superfamily
IPR013320 Concanavalin A-like lectin/glucanase domain superfamilyFamilyHomologous superfamily
IPR017857 Coagulation factor-like, Gla domain superfamilyFamilyHomologous superfamily
IPR018097 EGF-like calcium-binding, conserved siteSiteConserved site
IPR033189 Vitamin K-dependent protein SFamilyFamily
IPR035972 Gamma-carboxyglutamic acid-rich (GLA) domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612336 OMIMThrombophilia due to protein S deficiency, autosomal dominant (THPH5)A hemostatic disorder characterized by impaired regulation of blood coagulation and a tendency to recurrent venous thrombosis. Based on the plasma levels of total and free PROS1 as well as the serine protease-activated protein C cofactor activity, three types of THPH5 have been described: type I, characterized by reduced total and free PROS1 levels together with reduced anticoagulant activity; type III, in which only free PROS1 antigen and PROS1 activity levels are reduced; and the rare type II which is characterized by normal concentrations of both total and free PROS1 antigen, but low cofactor activity. The disease is caused by variants affecting the gene represented in this entry.
614514 OMIMThrombophilia due to protein S deficiency, autosomal recessive (THPH6)A very rare and severe hematologic disorder resulting in thrombosis and secondary hemorrhage usually beginning in early infancy. Some affected individuals develop neonatal purpura fulminans, multifocal thrombosis, or intracranial hemorrhage. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00055 Drotrecogin alfaDrugbankbiotech
DB00170 MenadioneDrugbanksmall molecule
DB00464 Sodium tetradecyl sulfateDrugbanksmall molecule
DB09332 KappadioneDrugbanksmall molecule